Cover Image

Successful use of dupilumab in recalcitrant pediatric atopic dermatitis-like graft-versus-host disease: A case series

Saved in:

Bibliographic Details
Main Authors:	Lina Belmesk, MD (Author), Afshin Hatami, MD (Author), Julie Powell, MD (Author), Victor Kokta, MD (Author), Jerome Coulombe, MD (Author)
Format:	Book
Published:	Elsevier, 2024-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Recalcitrant erythrodermic ichthyosis with atopic dermatitis successfully treated with Dupilumab in combination with Guselkumab
by: M. Steinhoff, et al.
Published: (2022)

Recalcitrant Palmar-Plantar Atopic Dermatitis Successfully Treated with Dupilumab: A Case Series
by: Deng L, et al.
Published: (2022)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
by: Amanda E. Zubek, MD, PhD, et al.
Published: (2021)

Recalcitrant palmoplantar pustulosis controlled with dupilumab
by: Hannah D. Smith, BA, et al.
Published: (2023)

Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
by: Maria Esposito, MD, et al.
Published: (2023)

Letter in response to the case report: "Recalcitrant generalized granuloma annulare treated successfully with dupilumab"
by: Claudia Paganini, MD, et al.
Published: (2023)

Alopecia areata after dupilumab for atopic dermatitis
by: Krystal Mitchell, MBA, et al.
Published: (2018)

Recalcitrant bullous pemphigoid responsive to dupilumab in an adolescent patient
by: Albert E. Zhou, MD, PhD, et al.
Published: (2022)

Relapsing-remitting multiple sclerosis arising in a patient with atopic dermatitis on dupilumab
by: Leah Laageide, MD, et al.
Published: (2021)

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
by: Danielle M. Peterson, MD, et al.
Published: (2021)

Recalcitrant generalized granuloma annulare treated successfully with dupilumab
by: Eingun James Song, MD, et al.
Published: (2021)

Recalcitrant Hailey-Hailey disease successfully treated with topical ruxolitinib cream and dupilumab
by: Juna Khang, BA, et al.
Published: (2023)

The use of dupilumab for the treatment of recalcitrant brachioradial pruritus
by: Mary Kathryn Abel, AB, et al.
Published: (2021)

A case report of uveitis secondary to dupilumab treatment for atopic dermatitis
by: Marissa Ayasse, BS, et al.
Published: (2021)

Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris
by: Angela Y. Moore, MD, et al.
Published: (2023)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
by: Sung Kyung Cho, BA, et al.
Published: (2021)

Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: A case report
by: Madeeha Mian, MD, et al.
Published: (2020)

Recalcitrant anal and genital pruritus treated with dupilumab
by: E.J. Yang, BS, et al.
Published: (2018)

Dupilumab-induced phenotype switching from atopic dermatitis to psoriasis
by: Aakaash Varma, BA, et al.
Published: (2020)

Refractory pruritus responds to dupilumab in a patient with TTC7A mutation
by: Yassaman Alipour Tehrany, MD, et al.
Published: (2021)

Alcohol-induced facial flushing in a patient with atopic dermatitis treated with dupilumab
by: Sean J. Igelman, BS, et al.
Published: (2020)

Drug-induced interstitial lung disease associated with dupilumab for the treatment of atopic dermatitis
by: Bethany F. Wilken, MSc, et al.
Published: (2024)

Prolonged hypereosinophilia associated with dupilumab for atopic dermatitis: A case series and review of literature
by: Gabriela Fonseca, BS, et al.
Published: (2024)

Dupilumab improved atopic dermatitis without aggravating tuberculous eosinophilic pleural effusion in hyperimmunoglobulin-E syndrome
by: Piyaporn Chokevittaya, MD, et al.
Published: (2024)

Treatment efficacy of dupilumab in a hyper-immunoglobulin E syndrome patient with severe atopic dermatitis
by: Chia-Jui Su, MD, et al.
Published: (2021)

Severe cutaneous reaction with initiation of dupilumab for atopic dermatitis and prurigo nodularis: An unusual adverse effect
by: Leore Lavin, MSc, et al.
Published: (2024)

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
by: Neda Shahriari, MD, et al.
Published: (2023)

Outcomes of systemic Janus kinase inhibitors following prior dupilumab use for atopic dermatitis: An evidence-based review
by: Siddhartha Sood, HBSc, et al.
Published: (2024)

Dupilumab-induced pityriasis rosea in a 28-year-old male with atopic dermatitis
by: Faraz Yousefian, DO, et al.
Published: (2024)

Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumabCapsule Summary
by: Francesco Bellinato, MD, et al.
Published: (2023)

Introduction of self-injection increases compliance with dupilumab administration in adult patients with atopic dermatitis: A single-center retrospective study
by: Makoto Ito, MD, et al.
Published: (2020)

Alopecia areata-like and psoriasis after dupilumab use for atopic dermatitis,
by: Viviane Maria Maiolini, et al.
Published: (2021)

Psoriasis‐like eruptions developed in an atopic dermatitis patient treated with dupilumab
by: Rai Fujimoto, et al.
Published: (2022)

Full scalp hair regrowth in a 4-year-old girl with alopecia areata and atopic dermatitis treated with dupilumab
by: Diana Gruenstein, BA, et al.
Published: (2020)

Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study
by: Jorge R. Georgakopoulos, MD, et al.
Published: (2021)

Peristomal irritant contact dermatitis treated with dupilumab
by: Emma Villamaria, BSA, et al.
Published: (2023)

Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023)

Dupilumab: One therapy to treat multiple atopic diseases
by: Fatima Bawany, BA, et al.
Published: (2020)

A real-world study of dupilumab in patients with atopic dermatitis including patients with malignancy and other medical comorbiditiesCapsule Summary
by: Dea Metko, BSc, et al.
Published: (2024)

Adalimumab in Recalcitrant Severe Psoriasis Associated with Atopic Dermatitis
by: Savas Yayli, et al.
Published: (2013)